Patent · US Active

Antigen-adjuvant compositions and methods

US8790658B2 · kind B2 · utility

1,002Cited by
5References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2008
Grant dateJul 29, 2014
Priority date
Expiry dateJul 25, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vitreous compositions of an antigen and adjuvant, and methods for making the compositions are disclosed. Also disclosed are pharmaceutically acceptable formulations of the vitreous compositions, reconstituted liquid formulations of the vitreous compositions, vaccine compositions, and kits containing the vitreous compositions. Also disclosed are devices for administering the vitreous compositions to mammals and methods for eliciting an immune response in mammals by administering the compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.